US Authorizes Moderna’s New COVID-19 Vaccine, mNexspike, With Usage Constraints
The United States granted authorization to Moderna’s novel COVID-19 vaccine, named mNexspike, albeit with certain usage constraints, late on a Friday. Rather than a replacement, it is designed to be an alternative to the organization’s existing vaccine. This recent development…
